These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

612 related items for PubMed ID: 16996605

  • 1. The International Classification of Retinoblastoma predicts chemoreduction success.
    Shields CL, Mashayekhi A, Au AK, Czyz C, Leahey A, Meadows AT, Shields JA.
    Ophthalmology; 2006 Dec; 113(12):2276-80. PubMed ID: 16996605
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors.
    Shields CL, Mashayekhi A, Cater J, Shelil A, Ness S, Meadows AT, Shields JA.
    Arch Ophthalmol; 2005 Jun; 123(6):765-73. PubMed ID: 15955977
    [Abstract] [Full Text] [Related]

  • 6. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma.
    Brichard B, De Bruycker JJ, De Potter P, Neven B, Vermylen C, Cornu G.
    Med Pediatr Oncol; 2002 Jun; 38(6):411-5. PubMed ID: 11984802
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Management and outcome of retinoblastoma with vitreous seeds.
    Manjandavida FP, Honavar SG, Reddy VA, Khanna R.
    Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Basic understanding of current classification and management of retinoblastoma.
    Shields CL, Shields JA.
    Curr Opin Ophthalmol; 2006 Jun; 17(3):228-34. PubMed ID: 16794434
    [Abstract] [Full Text] [Related]

  • 14. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
    Zage PE, Reitman AJ, Seshadri R, Weinstein JL, Mets MB, Zeid JL, Greenwald MJ, Strauss LC, Goldman S.
    Pediatr Blood Cancer; 2008 Mar; 50(3):567-72. PubMed ID: 17729249
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
    Shields CL, Honavar SG, Shields JA, Demirci H, Meadows AT, Naduvilath TJ.
    Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.